Related Experiment Videos

Mix-ups and mycoplasma: the enemies within

Leukemia Research
|February 13, 2002
PubMed

Insights

Human leukemia-lymphoma (LL) cell lines are often contaminated, with about one-third affected by cross-contamination or mycoplasma. DNA fingerprinting and cytogenetic analysis can detect and authenticate LL cell lines, preventing research errors.

Area of Science:

  • Cell Biology
  • Hematology
  • Genetics

Background:

  • Human leukemia-lymphoma (LL) cell lines are crucial for research but frequently suffer from cross-contamination with unrelated cells or microbial infections, particularly mycoplasma.
  • Approximately one-third of LL cell lines are compromised, potentially leading to inaccurate experimental results.
  • Misclassification of cell line identity further complicates their use in research.

Discussion:

  • Cross-contamination can occur early during establishment or late in existing cultures, with intrusive cells often having a growth advantage.
  • Mycoplasma infections introduce unpredictable effects on eukaryotic cells, compromising data integrity.
  • DNA fingerprinting and cytogenetic analysis are effective methods for detecting cross-contaminations and authenticating LL cell lines.

Key Insights:

  • Established methods exist for detecting and eliminating mycoplasma contamination.
  • Early and late cross-contamination present distinct challenges in LL cell line establishment and maintenance.
  • Accurate authentication of LL cell lines is vital to ensure reliable experimental outcomes.

Outlook:

  • Implementing diagnostic and preventive strategies is crucial to curb the rise of compromised LL cell lines.
  • Further research into robust authentication techniques will enhance the reliability of cell line-based studies.
  • Standardized protocols for mycoplasma detection and elimination are recommended for all cell line research.

Related Concept Videos